X-group (possible homology)

7562 Thiamin pyrophosphokinase, catalytic domain

Ligands and drugs

103
Member domains
29
with ligand contacts (≤ 4 Å)
28.2% of members
28
with DrugDomain annotations
27.2% of members
24
with a DrugBank compound
23.3% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

7
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Organoheterocyclic compounds71.16.59×not tested
Homogeneous metal compounds63.41.77×not tested
Organic oxygen compounds11.40.73×not tested
Nucleosides, nucleotides, and analogues11.90.52×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00152VIBThiamine11
DB04768PYIPyrithiamine Pyrophosphate3
DB00131AMPAdenosine phosphate1

Most frequently bound compounds

PDB ligandNameDomains in contact
MGmetalMAGNESIUM ION13
VIB3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM12
TPPTHIAMINE DIPHOSPHATE7
FEmetalFE (III) ION4
CAmetalCALCIUM ION2
NAmetalSODIUM ION2
PYI1-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-3-(2-{[HYDROXY(PHOSPHONOOXY)PHOSPHORYL]OXY}ETHYL)-2-METHYLPYRIDINIUM2
UNXUNKNOWN ATOM OR ION2
VNP3-[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]-5-(2-{[HYDROXY(PHOSPHONOAMINO)PHOSPHORYL]OXY}ETHYL)-4-METHYL-1,3-THIAZOL-3-IUM2
AMPADENOSINE MONOPHOSPHATE1